Home Newsfeeds Milestone Pharmaceuticals Q3 EPS $(0.34), Same YoY

Milestone Pharmaceuticals Q3 EPS $(0.34), Same YoY

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.34) per share. This is unchanged from the same period last year.

byBenzinga Newsdesk

November 10, 2022

1 minute read

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.34) per share. This is unchanged from the same period last year.

B. Riley Securities Downgrades Lumentum Holdings to Neutral, Lowers Price Target to $66

By Benzinga Newsdesk

February 10, 7:21 AM

B. Riley Securities analyst Dave Kang downgrades Lumentum Holdings (NASDAQ:LITE) from Buy to Neutral and lowers the price target from $90 to $66.

LITE

Exclusive: CoinFLEX CEO On ‘Bitcoin Jesus’ Roger Ver, Debt And Exchange Withdrawal Freeze

By Benzinga Newsdesk

July 7, 6:34 PM

In the second half of Benzinga’s latest “Moon or Bust”crypto livestream hosts Ryan McNamara and Aaron Bry interviewed Mark Lamb, co-founder and CEO of CoinFLEX, a company committed to providing institutions and retail investors an easily accessible platform to earn and trade, and incudes a futures exch

TWTR